Table 2

Data recorded for ALTH and NLTH groups

ALTH group (n = 413)NLTH group (n = 69)p Value
Age (years) at first neuro-ophthalmology visit52.0 (15.4)56.0 (13.5)0.02
Age (years) at first ocular dysfunction49.0 (15.6)54.4 (13.4)0.004
Difference between age at 1st neuro-ophthalmology visit and 1st ocular dysfunction2.7 (5.3)1.3 (2.5)0.02
BMI23.4 (4.0)26.3 (5.6)<0.001
Age adjusted (mean (SE))23.4 (0.3)26.1 (0.8)0.001
Sex
    Male98 (24%)34 (49%)<0.001
    Female315 (76%)35 (51%)
Race
    White249 (60.3%)43 (62.3%)0.34
    African-American27 (6.5%)2 (2.9%)
    Hispanic31 (7.5%)9 (13.0%)
    Asian43 (10.4%)4 (5.8%)
    Other63 (15.3%)11 (15.9%)
Medical treatment for ophthalmopathy140 (34%)17 (25%)0.17
Eye surgery217 (53%)23 (33%)0.004
Autoimmune17 (4%)5 (7%)0.23
Family history thyroid disease99 (24%)7 (10%)0.01
History of radiation treatment for Graves’ ophthalmopathy18 (4%)1 (1.5%)0.50
Hypercholesterol31 (7.5%)13 (19%)0.006
Surgeries
    Decompression100 (24%)5 (7%)<0.001
    Strabismus208 (50%)18 (26%)<0.001
    Levator88 (21%)5 (7%)0.005
    Lower lid retraction35 (8%)5 (7%)1.00
    Blepharoplasty64 (16%)7 (10%)0.28